TITLE

2010 - Review: Laparoscopic fundoplication is better than medical management for some quality-of-life measures in GERD

AUTHOR(S)
Romero, Yvonne
PUB. DATE
September 2010
SOURCE
ACP Journal Club;9/21/2010, Vol. 153 Issue 3, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study establishing whether the laparoscopic fundoplication surgery (LFS) is more effective than medical management for some quality-of-life measures recommended in the treatment of gastroesophageal reflux disease (GERD). According to the randomized controlled trials (RCTs) by S. M. Wileman and colleagues, LFS was beneficial for short-term improvements only. A chart presenting comparison between LFS and medical management for GERD, is also presented.
ACCESSION #
54115041

 

Related Articles

  • MELATONIN FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE. Werbach, Melvyn R. // Alternative Therapies in Health & Medicine;Jul/Aug2008, Vol. 14 Issue 4, p54 

    The enterochromaffin cells of the gastrointestinal (GI) tract secrete 400 times as much melatonin as the pineal gland; therefore, it is not surprising that research is finding that this indole plays an important role in GI functioning. In animal studies, it protects against GI ulcerations, and...

  • Rabeprazole 20 mg for Erosive Esophagitis-Associated Symptoms in a Large, Community-Based Study: Additional Results. Cutler, Alan; Robinson, Malcolm; Murthy, Anita; DeLemos, Byron // Digestive Diseases & Sciences;Feb2010, Vol. 55 Issue 2, p338 

    To provide additional efficacy data in patients treated with rabeprazole through week 4, and to validate sustained relief of gastroesophageal reflux disease symptoms through week 8 as well as to further analyze rabeprazole safety in patients with wide-ranging demographic and clinical...

  • Items of Interest. Rollins, Judy A. // Pediatric Nursing;Mar/Apr2007, Vol. 33 Issue 2, p183 

    The article focuses on the safety and efficacy of AXID Oral Solution (OS) for treating infants suffering from gastroesophageal reflux disease (GERD). This Phase III clinical trial was sponsored by the Braintree Laboratories. It aims to evaluate the efficacy, acceptability and safety of AXID OS...

  • Long-Term Results of Radiofrequency Energy Delivery for the Treatment of GERD: Results of a Prospective 48-Month Study. Dughera, Luca; Navino, Monica; Cassolino, Paola; De Cento, Mariella; Cacciotella, Luca; CisarĂ², Fabio; Chiaverina, Michele // Diagnostic & Therapeutic Endoscopy;2011, p1 

    Since 2000, radiofrequency (RF) energy treatment has been increasingly offered as an alternative option to invasive surgical procedures for selected patients with gastroesophageal reflux disease (GERD). Out of 69 patients treated since June 2002 to December 2007 with the Stretta procedure, 56 of...

  • Which patients with gastroesophageal reflux disease (GERD) should have esophagogastroduoudenoscopy (EGD)? Danis, Peter; Chumley, Heidi // Journal of Family Practice;Aug2001, Vol. 50 Issue 8, p658 

    This article examines the effectiveness of espohagogastroduoudenoscopy (EGD) in patients with gastroesophageal reflux disease (GERD). Patients with GERD referred for elective EGD who were found to have Barrett's esophagus were more likely to have symptoms for more than 1 year than patients who...

  • Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications. Koch, Oliver; Kaindlstorfer, Adolf; Antoniou, Stavros; Luketina, Ruzica; Emmanuel, Klaus; Pointner, Rudolph // Surgical Endoscopy;Jul2013, Vol. 27 Issue 7, p2383 

    Background: The fundoplication of choice for the surgical treatment of gastroesophageal reflux disease (GERD) still is debated. Multichannel intraluminal impedance monitoring (MII) has not been used to compare objective data, and comparative subjective data on laparoscopic Nissen and Toupet...

  • Current Pharmacological Management of Gastroesophageal Reflux Disease. Yao-Kuang Wang; Wen-Hung Hsu; Wang, Sophie S. W.; Chien-Yu Lu; Fu-Chen Kuo; Yu-Chung Su; Sheau-Fang Yang; Chiao-Yun Chen; Deng-Chyang Wu; Chao-Hung Kuo // Gastroenterology Research & Practice;2013, p1 

    Gastroesophageal reflux disease (GERD), a common disorder with troublesome symptoms caused by reflux of gastric contents into the esophagus, has adverse impact on quality of life. A variety of medications have been used in GERD treatment, and acid suppression therapy is the mainstay of treatment...

  • An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease. Mathews, Sony; Reid, Ashley; Chenlu Tian; Qiang Cai // Clinical & Experimental Gastroenterology;2010, Vol. 3, p11 

    Gastroesophageal reflux disease (GERD) is a chronic, recurrent disease that affects nearly 19 million people in the US. The mainstay of therapy for GERD is acid suppression. Proton pump inhibitors (PPIs) are the most effective medication for both initial treatment and maintenance therapy of...

  • Medical Therapy for Reflux Esophagitis: 1986 and Beyond. Castell, Donald O. // Annals of Internal Medicine;Jan86, Vol. 104 Issue 1, p112 

    Editorial. Addresses the status and future prospects for medical treatment of reflux esophagitis in the U.S. Details of studies on advances in therapies; Potential weaknesses of some clinical trials; Approach that is most promising.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics